Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Huebner

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Nature|February 5, 2011
Molecular biology: DNA fragility put into contextKay Huebner
Genes, Chromosomes & Cancer|December 23, 2018
PREFACEKay Huebner
Molecular Cancer Research : MCR|August 4, 2006
Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppressionShuho Semba, Kay Huebner
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2014
WWOX: a fragile tumor suppressorMorgan S Schrock, Kay Huebner
Future Oncology (London, England)|February 12, 2010
WWOX gene and gene product: tumor suppression through specific protein interactionsZaidoun Salah, Rami Aqeilan, Kay Huebner
Cell Cycle (Georgetown, Tex.)|April 26, 2007
A Fhit-ing role in the DNA damage checkpoint responseHideshi Ishii, Ya Wang, Kay Huebner
Genomics|March 7, 2003
Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancerShuang-Yin Han, Teresa Druck, Kay Huebner
Journal of Cellular Biochemistry|January 19, 2010
Pathology and biology associated with the fragile FHIT gene and gene productJoshua C Saldivar, Hidetaka Shibata, Kay Huebner
Cancers|June 6, 2014
Replicative Stress and the FHIT Gene: Roles in Tumor Suppression, Genome Stability and Prevention of CarcinogenesisJenna R Karras, Carolyn A Paisie, Kay Huebner
Cancer Biology & Therapy|November 15, 2002
FHIT as tumor suppressor: mechanisms and therapeutic opportunitiesYuri Pekarsky, Alexey Palamarchuk, Kay Huebner, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Nature|February 5, 2011
Molecular biology: DNA fragility put into contextKay Huebner
Genes, Chromosomes & Cancer|December 23, 2018
PREFACEKay Huebner
Molecular Cancer Research : MCR|August 4, 2006
Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppressionShuho Semba, Kay Huebner
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2014
WWOX: a fragile tumor suppressorMorgan S Schrock, Kay Huebner
Future Oncology (London, England)|February 12, 2010
WWOX gene and gene product: tumor suppression through specific protein interactionsZaidoun Salah, Rami Aqeilan, Kay Huebner
Cell Cycle (Georgetown, Tex.)|April 26, 2007
A Fhit-ing role in the DNA damage checkpoint responseHideshi Ishii, Ya Wang, Kay Huebner
Genomics|March 7, 2003
Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancerShuang-Yin Han, Teresa Druck, Kay Huebner
Journal of Cellular Biochemistry|January 19, 2010
Pathology and biology associated with the fragile FHIT gene and gene productJoshua C Saldivar, Hidetaka Shibata, Kay Huebner
Cancers|June 6, 2014
Replicative Stress and the FHIT Gene: Roles in Tumor Suppression, Genome Stability and Prevention of CarcinogenesisJenna R Karras, Carolyn A Paisie, Kay Huebner
Cancer Biology & Therapy|November 15, 2002
FHIT as tumor suppressor: mechanisms and therapeutic opportunitiesYuri Pekarsky, Alexey Palamarchuk, Kay Huebner, et al.
Pageof 11